Empagliflozin—A New Chance for Patients with Chronic Heart Failure.Published in:Pharmaceuticals (14248247), 2022, v. 15, n. 1, p. 47, doi. 10.3390/ph15010047By:Kowalska, Klaudia;Walczak, Justyna;Femlak, Joanna;Młynarska, Ewelina;Franczyk, Beata;Rysz, JacekPublication type:Article